Starry Gene Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series A2
- Investors
-
12
Starry Gene General Information
Description
Developer of gene therapy drugs designed for the treatment of ophthalmic diseases. The company utilizes adeno-associated virus vectors, bispecific antibody optimization, capsid screening, gene editing, targeted-reca enhanced homology-directed repair, and base editing, enabling healthcare providers to reduce injection frequency and achieve long-term therapeutic outcomes for patients.
Contact Information
Website
www.starrygene.comCorporate Office
- Huisheng Building, Advanced Technology Research Institute, University of Science and
- Technology of China, Number 5089 Wangjiang West Road, High-tech Zone
- Hefei, Anhui 230088
- China
Corporate Office
- Huisheng Building, Advanced Technology Research Institute, University of Science and
- Technology of China, Number 5089 Wangjiang West Road, High-tech Zone
- Hefei, Anhui 230088
- China
Starry Gene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A2) | 12-Sep-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 29-Feb-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 17-Jun-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 23-Mar-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 09-Nov-2020 | $4.48M | $4.48M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Aug-2019 | Completed | Startup |
Starry Gene Signals
Starry Gene Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guoyao Venture Capital | Venture Capital | Minority | ||
| KSCY Holding Group | Asset Manager | Minority | ||
| The Chinese Academy of Sciences Venture Capital Management | Venture Capital | Minority | ||
| Co-Win Ventures | Venture Capital | Minority | ||
| Hefei Innovation Technology Venture Capital | Growth/Expansion | Minority |
Starry Gene FAQs
-
When was Starry Gene founded?
Starry Gene was founded in 2019.
-
Where is Starry Gene headquartered?
Starry Gene is headquartered in Hefei, China.
-
What is the size of Starry Gene?
Starry Gene has 30 total employees.
-
What industry is Starry Gene in?
Starry Gene’s primary industry is Drug Discovery.
-
Is Starry Gene a private or public company?
Starry Gene is a Private company.
-
What is Starry Gene’s current revenue?
The current revenue for Starry Gene is .
-
How much funding has Starry Gene raised over time?
Starry Gene has raised $4.48M.
-
Who are Starry Gene’s investors?
Guoyao Venture Capital, KSCY Holding Group, The Chinese Academy of Sciences Venture Capital Management, Co-Win Ventures, and Hefei Innovation Technology Venture Capital are 5 of 12 investors who have invested in Starry Gene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process